Measles immunisation: profit and loss in a general practice

Area of Science:

• Public Health
• Epidemiology
• Immunization Practices

Background:

• Measles remains a significant public health concern in Britain.
• The efficacy and safety of measles immunisation are well-established.
• Comparison with measles prevalence in the United States highlights a disparity.

Purpose of the Study:

• To assess the occurrence of measles and immunisation rates in a specific patient cohort.
• To evaluate the impact of measles immunisation on general practice workload and financial outcomes.
• To explore reasons for the differing prevalence of measles in Britain compared to the United States.

Main Methods:

• A survey was conducted in a single general practice.
• Data collected on measles occurrence and immunisation status for patients born between 1963 and 1982.
• Consultation rates related to measles and home visit requirements were analyzed.

Main Results:

• Measles immunisation provided financial benefits to the general practice.
• Preventing measles through immunisation reduced measles-related consultations by 40%.
• Measles disease was three times more likely to necessitate a home visit than immunisation.

Conclusions:

• Measles immunisation is cost-effective and reduces healthcare utilization.
• Despite proven benefits, measles immunisation uptake or effectiveness may be suboptimal in Britain.
• Further investigation is warranted to understand why measles is not as rare in Britain as in the United States.